Olszanski, Anthony: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

Ribas, Antoni, Dummer, Reinhard, Puzanov, Igor, VanderWalde, Ari, Andtbacka, Robert H.I., Michielin, Olivier, Olszanski, Anthony J., Malvehy, Josep, Cebon, Jonathan, Fernandez, Eugenio, Kirkwood, John

Journal:

Year:

2017

Language:

english

File:

PDF, 4.18 MB

english, 2017

2

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

Ribas, Antoni, Dummer, Reinhard, Puzanov, Igor, VanderWalde, Ari, Andtbacka, Robert H.I., Michielin, Olivier, Olszanski, Anthony J., Malvehy, Josep, Cebon, Jonathan, Fernandez, Eugenio, Kirkwood, John

Journal:

Year:

2018

Language:

english

File:

PDF, 520 KB

english, 2018

3

Pharmacokinetic evaluation of axitinib

Patson, Brian, B Cohen, Roger, Olszanski, Anthony J.

Journal:

Expert Opinion on Drug Metabolism & Toxicology

Year:

2012

Language:

english

File:

PDF, 421 KB

english, 2012

4

Docetaxel and Gemcitabine: A Nonplatinum Combination for Non–Small-Cell Lung Cancer

Anthony J. Olszanski, James R. Rigas

Journal:

Clinical Lung Cancer

Year:

2000

Language:

english

File:

PDF, 112 KB

english, 2000

5

Outcomes in patients with mucosal melanomas

Keller, Deborah S., Thomay, Alan A., Gaughan, John, Olszanski, Anthony, Wu, Hong, Berger, Adam C., Farma, Jeffrey M.

Journal:

Journal of Surgical Oncology

Year:

2013

Language:

english

File:

PDF, 199 KB

english, 2013

6

Donor Transmission of Melanoma Following Renal Transplant

Chen, Kathryn T., Olszanski, Anthony, Farma, Jeffrey M.

Journal:

Case Reports in Transplantation

Year:

2012

Language:

english

File:

PDF, 493 KB

english, 2012

7

Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors

Zibelman, Matthew, Wong, Yu-Ning, Devarajan, Karthik, Malizzia, Lois, Corrigan, Alycia, Olszanski, Anthony J., Denlinger, Crystal S., Roethke, Susan K., Tetzlaff, Colleen H., Plimack, Elizabeth R.

Journal:

Investigational New Drugs

Year:

2015

Language:

english

File:

PDF, 1.19 MB

english, 2015

8

Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral gemcitabine prodrug, in patients with advanced solid tumors

Faivre, Sandrine J., Olszanski, Anthony J., Weigang-Köhler, Karin, Riess, Hanno, Cohen, Roger B., Wang, Xuejing, Myrand, Scott P., Wickremsinhe, Enaksha R., Horn, Candice L., Ouyang, Haojun, Callies,

Journal:

Investigational New Drugs

Year:

2015

Language:

english

File:

PDF, 790 KB

english, 2015

9

Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab

Zibelman, Matthew, Pollak, Natasha, Olszanski, Anthony J

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2016

Language:

english

File:

PDF, 2.47 MB

english, 2016

10

Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer

Boland, Patrick M., Meyer, Joshua E., Berger, Adam C., Cohen, Steven J., Neuman, Tzahi, Cooper, Harry S., Olszanski, Anthony J., Davey, Monica, Cheng, Jonathan D., Lebenthal, Abraham, Burtness, Barbar

Journal:

American Journal of Clinical Oncology

Year:

2016

Language:

english

File:

PDF, 141 KB

english, 2016

11

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

Rixe, Olivier, Puzanov, Igor, LoRusso, Patricia M., Cohen, Roger B., Morris, John C., Olowokure, Olugbenga O., Yin, Jian Y., Doroumian, Séverine, Shen, Liji, Olszanski, Anthony J.

Journal:

Anti-Cancer Drugs

Year:

2015

Language:

english

File:

PDF, 265 KB

english, 2015

12

Phase 1 study evaluating the safety and pharmacokinetics of pralatrexate in relapsed/refractory advanced solid tumors and lymphoma patients with mild, moderate, and severe renal impairment

Kelly, Kevin R., Gabrail, Nashat, Weitman, Steven, Sarantopoulos, John, Olszanski, Anthony J., Edenfield, William, Venitz, Jurgen, Reddy, Guru, Yang, Allen, Hasal, Steven J., Lockhart, A. Craig

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2016

Language:

english

File:

PDF, 468 KB

english, 2016

13

Successful imatinib therapy for neuroendocrine carcinoma with activating KIT mutation: A case study

Perkins, James, Boland, Patrick, Cohen, Steven J., Olszanski, Anthony J., Zhou, Yan, Engstrom, Paul, Astsaturov, Igor

Journal:

JNCCN Journal of the National Comprehensive Cancer Network

Year:

2014

Language:

english

File:

PDF, 1.33 MB

english, 2014

14

Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer

Infante, Jeffrey R., Patnaik, Amita, Verschraegen, Claire F., Olszanski, Anthony J., Shaheen, Montaser, Burris, Howard A., Tolcher, Anthony W., Papadopoulos, Kyriakos P., Beeram, Muralidhar, Hynes, Sc

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2017

Language:

english

File:

PDF, 886 KB

english, 2017

15

P2.03a-018 A Phase I/II Study of Alisertib, an Oral Aurora Kinase Inhibitor, in Combination with Erlotinib in Patients with Recurrent or Metastatic NSCLC

Godwin, James, Bauman, Jessica, Litwin, Samuel, Mehra, Ranee, Olszanski, Anthony, Borghaei, Hossein

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 175 KB

english, 2017

16

Principles of Immunotherapy

Olszanski, Anthony J.

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2015

Language:

english

File:

PDF, 153 KB

english, 2015

17

Progress in the Management of Melanoma in 2013

Coit, Daniel G., Olszanski, Anthony J.

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2013

Language:

english

File:

PDF, 233 KB

english, 2013

18

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys

Kurzrock, Razelle, Colevas, A. Dimitrios, Olszanski, Anthony, Akerley, Wallace, Arteaga, Carlos L., Carson, William E., Clark, Jeffrey W., DiPersio, John F., Ettinger, David S., Morgan, Robert J., Sch

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2015

Language:

english

File:

PDF, 508 KB

english, 2015

19

First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients With Advanced Solid Tumors

Papadopoulos, Kyriakos P., Gluck, Larry, Martin, Lainie P., Olszanski, Anthony J., Tolcher, Anthony W, Ngarmchamnanrith, Gataree, Rasmussen, Erik, Amore, Benny, Nagorsen, Dirk, Hill, John S., Stephens

Journal:

Clinical Cancer Research

Year:

2017

Language:

english

File:

PDF, 809 KB

english, 2017

20

Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate

Hussaini, Azra, Olszanski, Anthony J., Stein, Cy A., Bosch, Bill, Nemeth, Paul

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2017

Language:

english

File:

PDF, 787 KB

english, 2017

21

Successful Imatinib Therapy for Neuroendocrine Carcinoma With Activating KIT Mutation: A Case Study

Perkins, James, Boland, Patrick, Cohen, Steven J., Olszanski, Anthony J., Zhou, Yan, Engstrom, Paul, Astsaturov, Igor

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2014

Language:

english

File:

PDF, 323 KB

english, 2014

22

The Effect of Food on the Absorption of Abiraterone Acetate from a Fine Particle Dosage Form: A Randomized Crossover Trial in Healthy Volunteers

Papangelou, Alexander, Olszanski, Anthony J., Stein, Cy Aaron, Bosch, Bill, Nemeth, Paul

Journal:

Oncology and Therapy

Year:

2017

Language:

english

File:

PDF, 528 KB

english, 2017

23

A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265)

Long, Georgina V, Dummer, Reinhard, Ribas, Antoni, Puzanov, Igor, Michielin, Olivier, VanderWalde, Ari, Andtbacka, Robert HI, Cebon, Jonathan, Fernandez, Eugenio, Malvehy, Josep, Olszanski, Anthony J,

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2015

Language:

english

File:

PDF, 256 KB

english, 2015

24

Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma

Olszanski, Anthony J.

Journal:

Journal of managed care pharmacy

Year:

2014

Language:

english

File:

PDF, 552 KB

english, 2014

25

First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors

Moore, Kathleen N., Bendell, Johanna C., LoRusso, Patricia M., Olszanski, Anthony J., Zwick-Wallasch, Esther, Jansen, Mendel, Vandell, Alexander G., Senaldi, Giorgio

Journal:

Investigational New Drugs

Year:

2018

Language:

english

File:

PDF, 1.27 MB

english, 2018

26

Melanoma in the Bronchus

Manley, Christopher, Olszanski, Anthony

Journal:

New England Journal of Medicine

Year:

2018

Language:

english

File:

PDF, 241 KB

english, 2018

27

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105

Drilon, Alexander, Fu, Siqing, Patel, Manish R., Fakih, Marwan, Wang, Ding, Olszanski, Anthony J., Morgensztern, Daniel, Liu, Stephen V., Cho, Byoung Chul, Bazhenova, Lyudmila, Rodriguez, Cristina P,

Journal:

Cancer Discovery

Year:

2018

Language:

english

File:

PDF, 3.09 MB

english, 2018

28

Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma

Gibney, Geoffrey T., Hamid, Omid, Lutzky, Jose, Olszanski, Anthony J., Mitchell, Tara C., Gajewski, Thomas F., Chmielowski, Bartosz, Hanks, Brent A., Zhao, Yufan, Newton, Robert C., Maleski, Janet, Le

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2019

File:

PDF, 976 KB

2019

29

Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma

Gibney, Geoffrey T., Hamid, Omid, Lutzky, Jose, Olszanski, Anthony J., Mitchell, Tara C., Gajewski, Thomas F., Chmielowski, Bartosz, Hanks, Brent A., Zhao, Yufan, Newton, Robert C., Maleski, Janet, Le

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2019

Language:

english

File:

PDF, 976 KB

english, 2019

30

Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)

Mitchell, Tara C., Hamid, Omid, Smith, David C., Bauer, Todd M., Wasser, Jeffrey S., Olszanski, Anthony J., Luke, Jason J., Balmanoukian, Ani S., Schmidt, Emmett V., Zhao, Yufan, Gong, Xiaohua, Malesk

Journal:

Journal of Clinical Oncology

Year:

2018

Language:

english

File:

PDF, 785 KB

english, 2018

31

Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies

Nakhoda, Shazia K., Olszanski, Anthony J.

Journal:

Pharmaceutical Medicine

Year:

2020

File:

PDF, 610 KB

2020

32

Assessment of effects of repeated oral doses of fedratinib on inhibition of cytochrome P450 activities in patients with solid tumors using a cocktail approach

Ogasawara, Ken, LoRusso, Patricia M., Olszanski, Anthony J., Rixe, Olivier, Xu, Christine, Yin, Jian, Palmisano, Maria, Krishna, Gopal

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2020

File:

PDF, 850 KB

2020

33

Primary Tumor Characteristics and Next Generation Sequencing Mutations as Biomarkers for Melanoma Immunotherapy Response

Loo, Kimberly, Gauvin, Gabrielle, Soliman, Iman, Renzetti, Madelyn, Deng, Mengying, Ross, Eric, Luo, Biao, Wu, Hong, Reddy, Sanjay, Olszanski, Anthony J., Farma, Jeffrey M.

Journal:

Pigment Cell & Melanoma Research

Year:

2020

File:

PDF, 843 KB

2020

34

Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors

Razak, Albiruni RA, Cleary, James M, Moreno, Victor, Boyer, Michael, Calvo Aller, Emiliano, Edenfield, William, Tie, Jeanne, Harvey, R Donald, Rutten, Annemie, Shah, Manish A, Olszanski, Anthony J, JÃ

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2020

File:

PDF, 643 KB

2020

35

O85âDurable responses in anti-PD-1 refractory melanoma following intratumoral injection of a toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab

Milhem, Mohammed, Zakharia, Yousef, Davar, Diwakar, Buchbinder, Elizabeth, Medina, Theresa, Daud, Adil, Ribas, Antoni, Niu, Jiaxin, Gibney, Geoffrey, Margolin, Kim, Olszanski, Anthony, Mehmi, Interjit

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2020

File:

PDF, 439 KB

2020

36

OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors

Gutierrez, Martin, Moreno, Victor, Heinhuis, Kimberley M., Olszanski, Anthony J., Spreafico, Anna, Ong, Michael, Chu, Quincy S, Carvajal, Richard D., Trigo, JosÃ©, Ochoa de Olza, Maria, Provencio, Mar

Journal:

Clinical Cancer Research

Year:

2020

File:

PDF, 1.26 MB

2020

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски